These composites inhibited glucose and glutamine uptake of pancreatic cancer cells through the released BAY-876 and V-9302, leading to nutrition deprivation and oxidative stress, activating caspase 1 and GSDMD, and finally, inducing pyroptosis. Here, GSDMD is linked to pancreatic neoplasm.